BIOS
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS
Delisted
BIOS was delisted on the 6th of October, 2023.
32 hedge funds and large institutions have $134M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
32
Holding in Top 10
1
Calls
$107K
Puts
–
Top Buyers
| 1 | +$10.7M | |
| 2 | +$4.85M | |
| 3 | +$4.32M | |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$3.83M |
| 5 |
CC
Centiva Capital
New York
|
+$3.51M |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$12M | |
| 3 | -$11.4M | |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$10.4M |
| 5 |
D.E. Shaw & Co
New York
|
-$9.33M |